We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$614M
AUM Growth
+$40M
Cap. Flow
-$7.96M
Cap. Flow %
-1.3%
Top 10 Hldgs %
29.7%
Holding
164
New
2
Increased
37
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.57M
2
IRM icon
Iron Mountain
IRM
+$626K
3
MMM icon
3M
MMM
+$589K
4
KYNB
Kyntra Bio
KYNB
+$490K
5
RTN
Raytheon Company
RTN
+$442K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.2M
2
SLB icon
SLB Ltd
SLB
+$1.83M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.01M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$605K

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 22.86%
3 Industrials 9.44%
4 Consumer Staples 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
101
Aldeyra Therapeutics
ALDX
$94.7M
$777K 0.13%
133,786
+34,945
+35% +$202K
LOW icon
102
Lowe's Companies
LOW
$122B
$751K 0.12%
6,268
-100
-2% -$11.4K
DHR icon
103
Danaher
DHR
$138B
$741K 0.12%
5,448
– –
NVS icon
104
Novartis
NVS
$293B
$714K 0.12%
7,542
-100
-1% -$8.97K
LEG icon
105
Leggett & Platt
LEG
$1.34B
$709K 0.12%
13,950
+100
+0.7% +$4.9K
CVX icon
106
Chevron
CVX
$367B
$701K 0.11%
5,819
– –
SPY icon
107
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$697K 0.11%
2,167
– –
FDX icon
108
FedEx
FDX
$75.1B
$638K 0.1%
4,218
+165
+4% +$25.4K
AMT icon
109
American Tower
AMT
$78.5B
$606K 0.1%
2,639
– –
SILC icon
110
Silicom
SILC
$254M
$590K 0.1%
17,729
– –
VKTX icon
111
Viking Therapeutics
VKTX
$3.96B
$587K 0.1%
73,151
+18,188
+33% +$133K
WFC icon
112
Wells Fargo
WFC
$268B
$574K 0.09%
10,669
– –
BLUE
113
DELISTED
bluebird bio
BLUE
$562K 0.09%
495
– –
HSY icon
114
Hershey
HSY
$36.2B
$558K 0.09%
3,795
– –
MOMO
115
Hello Group
MOMO
$854M
$532K 0.09%
15,890
– –
LIN icon
116
Linde
LIN
$227B
$509K 0.08%
2,393
– –
TROW icon
117
T. Rowe Price
TROW
$24.3B
$492K 0.08%
4,036
-590
-13% -$69.7K
NBL
118
DELISTED
Noble Energy, Inc.
NBL
$488K 0.08%
19,640
– –
HON icon
119
Honeywell
HON
$77.9B
$484K 0.08%
2,900
– –
LLY icon
120
Eli Lilly
LLY
$1.05T
$473K 0.08%
3,600
– –
VTI icon
121
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$462K 0.08%
2,825
– –
PDCE
122
DELISTED
PDC Energy, Inc.
PDCE
$428K 0.07%
16,345
– –
RP
123
DELISTED
RealPage, Inc.
RP
$424K 0.07%
7,882
– –
PAYX icon
124
Paychex
PAYX
$42.1B
$410K 0.07%
4,815
– –
DOV icon
125
Dover
DOV
$28.8B
$403K 0.07%
3,500
– –
3 4
5
6 7

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Woodstock Corp's Q4 2019 Portfolio in Review

As of Q4 2019, Woodstock Corp held 164 positions worth $614M, up 7% from $574M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodstock Corp's Q4 2019 filing shows 2 new, 37 increased, 65 reduced and 9 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K. The largest sale was Celgene Corp, an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K.
  • Woodstock Corp added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.57M increase.
  • Woodstock Corp's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $1.83M.
  • Woodstock Corp fully exited Celgene Corp in Q4 2019, selling an estimated $9.2M.
  • Woodstock Corp's ten largest holdings make up 30% of its $614M portfolio in Q4 2019.
  • Woodstock Corp opened 2 new positions and closed 9 in Q4 2019.
  • Woodstock Corp's portfolio value rose 7% quarter-over-quarter to $614M.

Based on Woodstock Corp's 13F filing for Q4 2019, filed 13 Jan 2020.